ArticleWorld journal of gastrointestinal pharmacology and therapeutics2025

Real-world-evidence, prospective-observational study to evaluate safety and effectiveness of rabeprazole dual-delayed-release capsules in patients with gastroesophageal reflux disease.

Parimal Lawate et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.